本页面由Tiger Trade Technology Pte. Ltd.提供服务

BIODEXA PHARMACEUTICALS PLC SPON ADS EACH REP 5 ORD

0.3865
-0.0737-16.01%
成交量:25.83万
成交额:10.67万
市值:39.77万
市盈率:-0.07
高:0.4700
开:0.4700
低:0.3800
收:0.4602
52周最高:52.05
52周最低:0.3800
股本:102.91万
流通股本:94.35万
量比:1.72
换手率:27.38%
股息:- -
股息率:- -
每股收益(TTM):-5.6940
每股收益(LYR):-78.3088
净资产收益率:-42.00%
总资产收益率:-40.11%
市净率:0.03
市盈率(LYR):0.00

数据加载中...

2024/11/07

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/08/16

SEC问询函

Form CORRESP - Correspondence
2024/08/12

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/08/09

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/07/23

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/06/12

SEC问询函

Form CORRESP - Correspondence
2024/06/06

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/04/19

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/03/21

SEC问询函

Form CORRESP - Correspondence
2024/03/18

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/09

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/12/28

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/12/16

SEC问询函

Form CORRESP - Correspondence
2023/12/16

SEC问询函

Form CORRESP - Correspondence
2023/12/15

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]